Research areas: glucose metabolism:
Glucose-dependent stimulation of insulin secretion by beta cells
Suppression of glucagon secretion
Skinni: a dual GIP and GLP-1 receptor agonist peptide
Research areas: energy metabolism:
Central regulation of feeding behaviour
Insulin sensitivity of adipose and muscle tissue
Glucose uptake by muscle tissue
Thermogenesis and energy expenditure
Cardiovascular and metabolic markers
Skinni is a synthetic lipidated 39-amino-acid peptide, a dual agonist of the GIP and GLP-1 receptors. It is used in laboratory research on incretin signalling and the regulation of energy metabolism.
Unlike selective GLP-1 receptor agonists, the molecule activates both incretin receptors, GIP and GLP-1. This makes it useful in comparative studies of each receptor's contribution to cellular and tissue responses.
How it differs from mono-agonists:
Cellular insulin sensitivity
Suppression of glucagon secretion
Glucose-dependent stimulation of insulin secretion by beta cells
Pancreatic beta-cell function
Research areas: glucose metabolism: